Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study
Sorafenib, an oral multikinase inhibitor, is approved for advanced hepatocellular carcinoma (HCC) treatment. However, its therapeutic effect in advanced HCC patients with extrahepatic metastasis remains uncertain. This study aimed to prospectively assess the efficacy, safety, and survival risk facto...
Main Authors: | Nakano, Masahito, Tanaka, Masatoshi, Kuromatsu, Ryoko, Nagamatsu, Hiroaki, Tajiri, Nobuyoshi, Satani, Manabu, Niizeki, Takashi, Aino, Hajime, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Koga, Hironori, Torimura, Takuji |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123720/ |
Similar Items
-
Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection
by: Sumie, Shuji, et al.
Published: (2011) -
Inhibition of hypoxia-inducible factor via upregulation of von Hippel-Lindau protein induces “angiogenic switch off” in a hepatoma mouse model
by: Iwamoto, Hideki, et al.
Published: (2015) -
Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases
by: KAWAGUCHI, TAKUMI, et al.
Published: (2014) -
Extrahepatic Portal Vein Aneurysm
by: Gaba, Ron C., et al.
Published: (2016) -
High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors
by: IKEZONO, YU, et al.
Published: (2015)